Literature DB >> 20645433

Modified non-overt DIC diagnostic criteria predict the early phase of overt-DIC.

Hideo Wada1, Tsuyoshi Hatada, Kohji Okamoto, Toshimasa Uchiyama, Kazuo Kawasugi, Toshihiko Mayumi, Satoshi Gando, Shigeki Kushimoto, Yoshinobu Seki, Seiji Madoiwa, Takashi Okamura, Cheng Hock Toh.   

Abstract

Diagnostic criteria for non-overt disseminated intravascular coagulation (DIC) have been proposed by the International Society of Thrombosis and Hemostasis, but are not useful for the diagnosis of early phase of overt-DIC (pre-DIC). Therefore, in the current study the non-overt DIC diagnostic criteria were modified using the global coagulation tests, the change rate in the global coagulation tests and molecular hemostatic markers to detect the pre-DIC state and were prospectively evaluated in 613 patients with underlying DIC disease. The frequencies of patients with DIC (DIC positive), late onset DIC, and without DIC (DIC absent) were 29.5%, 7.2%, and 63.3%, respectively. The modified non-overt-DIC criteria can correctly predict 43/44 patients (97.7%) who were DIC absent at admission and became DIC positive, within a week (late onset DIC state). The mortality rate was higher in DIC positive compared with pre-DIC (37.6% vs. 22.7%, P < 0.05) or DIC negative (37.6 vs. 13.7%, P < 0.01). It was also significantly higher in pre-DIC compared with DIC negative (P < 0.05). Thus, these modified non-overt DIC diagnostic criteria might therefore be useful for the diagnosis of early-phase DIC.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20645433     DOI: 10.1002/ajh.21783

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

Review 1.  Disseminated intravascular coagulation: a review for the internist.

Authors:  Marcel Levi; Tom van der Poll
Journal:  Intern Emerg Med       Date:  2012-09-27       Impact factor: 3.397

2.  The efficacy of the administration of recombinant human soluble thrombomodulin in patients with DIC.

Authors:  Takumi Aota; Hideo Wada; Yoshiki Yamashita; Takeshi Matsumoto; Kohshi Ohishi; Kei Suzuki; Hiroshi Imai; Masanobu Usui; Shuji Isaji; Naoyuki Katayama
Journal:  Int J Hematol       Date:  2015-11-21       Impact factor: 2.490

3.  Evidence of disseminated intravascular coagulation in a hemorrhagic fever with renal syndrome-scoring models and severe illness.

Authors:  Erik Sundberg; Johan Hultdin; Sofie Nilsson; Clas Ahlm
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

4.  Nonovert disseminated intravascular coagulation (DIC) in pregnancy: a new scoring system for the identification of patients at risk for obstetrical hemorrhage requiring blood product transfusion.

Authors:  Ali Alhousseini; Roberto Romero; Neta Benshalom-Tirosh; Dereje Gudicha; Percy Pacora; Dan Tirosh; Doron Kabiri; Lami Yeo; Jecko Thachil; Chaur-Dong Hsu; Sonia S Hassan; Offer Erez
Journal:  J Matern Fetal Neonatal Med       Date:  2020-02-03

Review 5.  Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines.

Authors:  Hideo Wada; Takeshi Matsumoto; Yoshiki Yamashita
Journal:  J Intensive Care       Date:  2014-02-20

6.  Disseminated intravascular coagulation and its immune mechanisms.

Authors:  Narcis I Popescu; Cristina Lupu; Florea Lupu
Journal:  Blood       Date:  2022-03-31       Impact factor: 25.476

7.  Thrombin-antithrombin complex measurement using a point-of-care testing device for diagnosis of disseminated intravascular coagulation in dogs.

Authors:  Kenji Rimpo; Aki Tanaka; Masayasu Ukai; Yuichi Ishikawa; Miyuki Hirabayashi; Toshihiro Shoyama
Journal:  PLoS One       Date:  2018-10-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.